BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12757932)

  • 1. p80 coilin, a coiled body-specific protein, interacts with ataxin-1, the SCA1 gene product.
    Hong S; Ka S; Kim S; Park Y; Kang S
    Biochim Biophys Acta; 2003 May; 1638(1):35-42. PubMed ID: 12757932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product.
    Hong S; Kim SJ; Ka S; Choi I; Kang S
    Mol Cell Neurosci; 2002 Jun; 20(2):298-306. PubMed ID: 12093161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO-1 interacts with mutant ataxin-1 and colocalizes to its aggregates in Purkinje cells of SCA1 transgenic mice.
    Kang S; Hong S
    Arch Ital Biol; 2010 Dec; 148(4):351-63. PubMed ID: 21308649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
    Yue S; Serra HG; Zoghbi HY; Orr HT
    Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a self-association region within the SCA1 gene product, ataxin-1.
    Burright EN; Davidson JD; Duvick LA; Koshy B; Zoghbi HY; Orr HT
    Hum Mol Genet; 1997 Apr; 6(4):513-8. PubMed ID: 9097953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
    Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT
    Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.
    Klement IA; Skinner PJ; Kaytor MD; Yi H; Hersch SM; Clark HB; Zoghbi HY; Orr HT
    Cell; 1998 Oct; 95(1):41-53. PubMed ID: 9778246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice.
    Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT
    Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of spinocerebellar ataxia type 1 disease.
    Kang S; Hong S
    Mol Cells; 2009 Jun; 27(6):621-7. PubMed ID: 19572115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures.
    Skinner PJ; Koshy BT; Cummings CJ; Klement IA; Helin K; Servadio A; Zoghbi HY; Orr HT
    Nature; 1997 Oct; 389(6654):971-4. PubMed ID: 9353120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel phosphorylation site in ataxin-1.
    Vierra-Green CA; Orr HT; Zoghbi HY; Ferrington DA
    Biochim Biophys Acta; 2005 May; 1744(1):11-8. PubMed ID: 15878393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.
    Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E
    Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin-conjugating enzyme UbcH6 regulates the transcriptional repression activity of the SCA1 gene product ataxin-1.
    Lee S; Hong S; Kang S
    Biochem Biophys Res Commun; 2008 Aug; 372(4):735-40. PubMed ID: 18519031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.
    Clark HB; Orr HT
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.
    Lim J; Crespo-Barreto J; Jafar-Nejad P; Bowman AB; Richman R; Hill DE; Orr HT; Zoghbi HY
    Nature; 2008 Apr; 452(7188):713-8. PubMed ID: 18337722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue transglutaminase crosslinks ataxin-1: possible role in SCA1 pathogenesis.
    D'Souza DR; Wei J; Shao Q; Hebert MD; Subramony SH; Vig PJ
    Neurosci Lett; 2006 Nov; 409(1):5-9. PubMed ID: 17045396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp70/Hsc70 regulates the effect phosphorylation has on stabilizing ataxin-1.
    Jorgensen ND; Andresen JM; Pitt JE; Swenson MA; Zoghbi HY; Orr HT
    J Neurochem; 2007 Sep; 102(6):2040-2048. PubMed ID: 17540008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration.
    Watase K; Weeber EJ; Xu B; Antalffy B; Yuva-Paylor L; Hashimoto K; Kano M; Atkinson R; Sun Y; Armstrong DL; Sweatt JD; Orr HT; Paylor R; Zoghbi HY
    Neuron; 2002 Jun; 34(6):905-19. PubMed ID: 12086639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel function of Ataxin-1 in the modulation of PP2A activity is dysregulated in the spinocerebellar ataxia type 1.
    Sánchez I; Piñol P; Corral-Juan M; Pandolfo M; Matilla-Dueñas A
    Hum Mol Genet; 2013 Sep; 22(17):3425-37. PubMed ID: 23630944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.